The Regeneron story began in 1988 with a simple passion for science. The company was founded on the principle that strong science would lead to important new medicines. Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST™ (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
Regeneron is a select team of people who share a passion for science, love to be challenged, welcome new ideas and thrive on research, development and innovation. Those who make the biggest contributions will rise to the top—regardless of organizational charts or hierarchy. What matters at Regeneron is that you have a passion for science and a drive to accelerate the development of new medicines.
Visit us at www.regeneron.com to learn more.